首页> 美国政府科技报告 >Evaluation of Pharmacokinetic Models for the Disposition of Lead (Pb) in Humans, in Support of Application to Occupational Exposure Limit Derivation.

【24h】

Evaluation of Pharmacokinetic Models for the Disposition of Lead (Pb) in Humans, in Support of Application to Occupational Exposure Limit Derivation.

机译：人体铅（pb）配置的药代动力学模型评价，支持应用于职业接触限值的推导。

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
Sweeny, L. M.;
展开▼
作者单位

展开▼
年度 2015
页码 1-48
总页数 48
原文格式 PDF
正文语种 eng
中图分类
关键词
Lead; pharmacokinetic modeling;

机译：铅;药代动力学模型;

相似文献

外文文献
中文文献
专利

1. A pharmacokinetic model of cis- and trans-permethrin disposition in rats and humans with aggregate exposure application [J] . Tornero-Velez,R., Davis,J., Scollon,E.J., Toxicological sciences: An official journal of the Society of Toxicology . 2012,第1期

机译：聚合暴露在大鼠和人体中顺式和反式氯菊酯的药代动力学模型
2. A Pharmacokinetic Model of cis- and trans-Permethrin Disposition in Rats and Humans With Aggregate Exposure Application [J] . Rogelio Tornero-Velez*1 Jimena Davis† Edward J. Scollon‡ James M. Starr* R. Woodrow Setzer† Michael-Rock Goldsmith* Daniel T. Chang* Jianping Xue* Valerie Zartarian* Michael J. De Vito§ and Michael F. Hughes‡ Toxicological Sciences . 2012,第1期

机译：应用总暴露的大鼠和人体内顺-和反-氯菊酯的药代动力学模型
3. Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations [J] . Hisham A. El-Masri, Tao Hong, Cara Henning, Environmental health perspectives. . 2018,第7期

机译：使用来自两个不同人群的数据评估无机砷暴露的基于生理的药代动力学（PBPK）模型
4. A Fuzzy Physiologically Based Pharmacokinetic Modeling Framework to Predict Drug Disposition in Humans [C] . Seng, Kok-Yong, Vicini, Engineering in Medicine and Biology Society, 2006 Annual International Conference of the IEEE . 2006

机译：一种基于模糊生理学的药代动力学建模框架，用于预测人类的药物处置
5. Integration of preclinical and clinical data with pharmacokinetic modeling and simulations to characterize the disposition of orally-active antiparasitic prodrugs and metabolites: Prediction of the dose-exposure relationship in humans. [D] . Yan, Zhixia. 2011

机译：临床前和临床数据与药代动力学建模和模拟的集成，以表征口服活性抗寄生虫前药和代谢物的分布：预测人类的剂量-暴露关系。
6. Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations [O] . Hisham A. El-Masri, Tao Hong, Cara Henning, 2018

机译：使用来自两个不同人群的数据评估无机砷暴露的基于生理的药代动力学（PBPK）模型
7. Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis [O] . STEPHEN WRING, ERIC GAUKEL, BAKELA NARE, 2013

机译：药代动力学和药效学利用未结合目标组织暴露作为基于处置的基本理由的一部分，用于苯并氧基阶段的阶段2人非洲锥虫病中的苯并氧基

Evaluation of Pharmacokinetic Models for the Disposition of Lead (Pb) in Humans, in Support of Application to Occupational Exposure Limit Derivation.

著录项

相似文献

相关主题

期刊订阅